Skip to main content

and
  1. Article

    Open Access

    Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma

    PARP inhibitors (PARPis) have clinical efficacy in BRCA-deficient cancers, but not BRCA-intact tumors, including glioblastoma (GBM). We show that MYC or MYCN amplification in patient-derived glioblastoma stem-lik...

    Jian-Fang Ning, Monica Stanciu, Melissa R. Humphrey, Joshua Gorham in Nature Communications (2019)

  2. Article

    Open Access

    Genetically distinct glioma stem-like cell xenografts established from paired glioblastoma samples harvested before and after molecularly targeted therapy

    Intratumoural heterogeneity underlies tumour escape from molecularly targeted therapy in glioblastoma. A cell-based model preserving the evolving molecular profiles of a tumour during treatment is key to under...

    Shota Tanaka, Samantha Luk, Juri Kiyokawa, Maristela L. Onozato in Scientific Reports (2019)

  3. No Access

    Article

    Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma

    A single sentence summarizing your paper (websum), which will appear online on the table of contents and in e-alerts, has been provided below. Please check this sentence for accuracy and appropriate emphasis.

    Itay Tirosh, Andrew S. Venteicher, Christine Hebert, Leah E. Escalante in Nature (2016)

  4. No Access

    Article

    Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22

    Bilateral acoustic neurofibromatosis (BANF) is a severe autosomal dominant disorder involving development of multiple tumours of the nervous system including meningiomas, gliomas, neurofibromas and particular...

    Guy A. Rouleau, Wladimir Wertelecki, Jonathan L. Haines, Wendy J. Hobbs in Nature (1987)

  5. No Access

    Article

    Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma

    The application of recombinant DNA techniques has identified two fundamental mechanisms of tumorigenesis in man. The first involves a qualitative or quantitative change in an oncogene (see ref. 1 for review). ...

    Bernd R. Seizinger, Robert L. Martuza, James F. Gusella in Nature (1986)